Psoriasis: current concepts and new approaches to therapy.
Psoriasis is a common disorder characterized by marked increases in keratinocyte proliferation, abnormal patterns of keratinocyte differentiation, prominent alterations in dermal capillary vasculature and the presence of dermal and epidermal T cells, monocytes/macrophages and neutrophils. It is now known that psoriasis can occur due to abnormalities in essential fatty acid metabolism, lymphokine secretion, free radical generation, lipid peroxidation and eicosanoid metabolism. It is possible to suppress almost completely psoriatic lesions by judicious use of methotrexate, cyclosporine A, and eicosapentaenoic acid. Our studies have shown that in patients with psoriasis there is an increase in the generation of free radicals with an alteration in essential fatty acid metabolism and that side-effects of anti-cancer drugs can be blocked by essential fatty acids in vivo. Thus, essential fatty acid metabolism seems to play a crucial role both in the pathogenesis and treatment of psoriasis.
Das
U N
UN
Department of Medicine, Nizam's Institute of Medical Sciences, Punjagutta, Hyderabad, India.
Vijaykumar
K
K
Madhavi
N
N
Suryaprabha
P
P
Sravankumar
G
G
Ramesh
G
G
Koratkar
R
R
Sagar
P S
PS
Padma
M
M
D016572:Cyclosporine / Q000627:therapeutic use; D004041:Dietary Fats; D015777:Eicosanoids / Q000378:metabolism; D015118:Eicosapentaenoic Acid / Q000627:therapeutic use; D005228:Fatty Acids, Essential / Q000502:physiology*; D006801:Humans; D007249:Inflammation; D008222:Lymphokines / Q000502:physiology; D008315:Malondialdehyde / Q000378:metabolism; D008954:Models, Biological; D011565:Psoriasis / Q000503:physiopathology* / Q000628:therapy*; D013481:Superoxides / Q000378:metabolism
D004041:Dietary Fats; D015777:Eicosanoids; D005228:Fatty Acids, Essential; D008222:Lymphokines; D013481:Superoxides; D008315:Malondialdehyde; D016572:Cyclosporine; D015118:Eicosapentaenoic Acid